<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704142</url>
  </required_header>
  <id_info>
    <org_study_id>UMassAmherst</org_study_id>
    <nct_id>NCT03704142</nct_id>
  </id_info>
  <brief_title>Comparison of PSAPs in Different Maskers</brief_title>
  <official_title>Personal Amplification Devices in Noise and Speech Maskers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Amherst</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Amherst</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will measure the performance of three personal amplification devices when used by
      middle-aged adults. Speech understanding will be assessed with two different types of
      background noises at three different input levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Speech understanding will be measured both unaided and aided with three different models of
      Personal Amplification devices (PSAPs). Sentences will be played to the participant from a
      loudspeaker located in front. Different types of background sounds (noise and other
      sentences) will be played from loudspeakers located to the right and left of the participant.
      Participants will be instructed to repeat back the sentence coming from the front. They also
      will rate subjective effort at the end of each block of trials.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">March 30, 2020</completion_date>
  <primary_completion_date type="Actual">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each participant will be tested with one of the models of devices.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of how three models of personal listening devices improve word understanding in noise</measure>
    <time_frame>One 2-hour lab session</time_frame>
    <description>Percentage of words that the participant can understand when using the Tweak Focus, the Bose Over-the-Counter hearing aids, or the Sound World Solutions CS 50+ personal listening devices</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Auditory Perception</condition>
  <arm_group>
    <arm_group_label>Tweak Focus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Speech understanding and listening effort will be assessed using the Tweak Focus personal sound amplifiers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IQ Earbuds</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Speech understanding and listening effort will be assessed using the IQEarbuds personal sound amplifiers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sound World Solutions CS50+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Speech understanding and listening effort will be assessed using the Sound World Solutions CS50+ personal sound amplifiers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bose Hearphones</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Speech understanding and listening effort will be assessed using the Sound World Solutions CS50+ personal sound amplifiers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sound World Solutions CS50+</intervention_name>
    <description>Participants will be tested using the Sound World Solutions CS 50+ hearing devices.</description>
    <arm_group_label>Sound World Solutions CS50+</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tweak Focus</intervention_name>
    <description>Participants will be tested using the Tweak Focus hearing devices.</description>
    <arm_group_label>Tweak Focus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IQ Earbuds</intervention_name>
    <description>Participants will be tested using the IQ Earbuds hearing devices.</description>
    <arm_group_label>IQ Earbuds</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bose Hearphones</intervention_name>
    <description>Participants will be tested using the Bose Hearphones hearing devices.</description>
    <arm_group_label>Bose Hearphones</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild high-frequency hearing loss (pure-tone thresholds of 25 dB HL - 45 dB HL between
             2000 Hz and 6000 Hz)

        Exclusion Criteria:

          -  history of prior hearing aid use

          -  history of neurologic or otologic disorders

          -  score of &lt; 26 on MOCA (cognitive screening tool)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Massachusetts Amherst</name>
      <address>
        <city>Amherst</city>
        <state>Massachusetts</state>
        <zip>01003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 6, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2018</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Amherst</investigator_affiliation>
    <investigator_full_name>Karen Helfer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

